Prothena Plc Stock Price Prediction

PRTA Stock  USD 14.53  0.75  5.44%   
At this time, the RSI of Prothena Plc's share price is approaching 34 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Prothena Plc, making its price go up or down.

Oversold Vs Overbought

34

 
Oversold
 
Overbought
The successful prediction of Prothena Plc's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Prothena plc, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Prothena Plc's stock price prediction:
EPS Estimate Next Quarter
(1.04)
EPS Estimate Current Year
(2.19)
EPS Estimate Next Year
(3.88)
Wall Street Target Price
60.4286
EPS Estimate Current Quarter
(1.18)
Using Prothena Plc hype-based prediction, you can estimate the value of Prothena plc from the perspective of Prothena Plc response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Prothena Plc to buy its stock at a price that has no basis in reality. In that case, they are not buying Prothena because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Prothena Plc after-hype prediction price

    
  USD 14.28  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Prothena Plc Basic Forecasting Models to cross-verify your projections.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prothena Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
12.4032.4636.93
Details
Naive
Forecast
LowNextHigh
11.5516.0220.49
Details
8 Analysts
Consensus
LowTargetHigh
81.3489.3999.22
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.6-0.55-0.45
Details

Prothena Plc After-Hype Price Prediction Density Analysis

As far as predicting the price of Prothena Plc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Prothena Plc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Prothena Plc, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Prothena Plc Estimiated After-Hype Price Volatility

In the context of predicting Prothena Plc's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Prothena Plc's historical news coverage. Prothena Plc's after-hype downside and upside margins for the prediction period are 9.81 and 18.75, respectively. We have considered Prothena Plc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
14.53
14.28
After-hype Price
18.75
Upside
Prothena Plc is not too volatile at this time. Analysis and calculation of next after-hype price of Prothena plc is based on 3 months time horizon.

Prothena Plc Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Prothena Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prothena Plc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Prothena Plc, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.45 
4.53
  0.41 
  0.44 
9 Events / Month
14 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
14.53
14.28
3.63 
492.39  
Notes

Prothena Plc Hype Timeline

Prothena plc is at this time traded for 14.53. The entity has historical hype elasticity of 0.41, and average elasticity to hype of competition of 0.44. Prothena is anticipated to increase in value after the next headline, with the price projected to jump to 14.28 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 3.63%, whereas the daily expected return is at this time at -0.45%. The volatility of related hype on Prothena Plc is about 464.09%, with the expected price after the next announcement by competition of 14.97. Prothena plc currently holds 11.84 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days.
Check out Prothena Plc Basic Forecasting Models to cross-verify your projections.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

Prothena Plc Related Hype Analysis

Having access to credible news sources related to Prothena Plc's direct competition is more important than ever and may enhance your ability to predict Prothena Plc's future price movements. Getting to know how Prothena Plc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Prothena Plc may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SCPHScpharmaceuticals(0.03)8 per month 0.00 (0.16) 4.30 (7.09) 20.70 
MISTMilestone Pharmaceuticals 0.14 5 per month 1.93  0.11  7.19 (2.72) 18.66 
ONCYOncolytics Biotech 1.65 19 per month 3.55 (0.02) 7.83 (6.67) 36.56 
MCRBSeres Therapeutics(0.03)9 per month 5.68  0.04  10.84 (9.78) 28.84 
LIFEATyr Pharma 0.03 1 per month 2.62  0.07  6.45 (5.29) 28.98 
ETNB89bio Inc(0.19)10 per month 0.00 (0.04) 5.01 (7.52) 27.43 
MDGLMadrigal Pharmaceuticals 15.47 8 per month 2.20  0.08  5.17 (3.96) 30.27 
PLRXPliant Therapeutics 0.22 9 per month 3.22  0.03  6.15 (5.67) 24.35 
ACLXArcellx 6.42 10 per month 2.98  0.1  6.65 (6.40) 15.13 
STOKStoke Therapeutics(0.45)5 per month 0.00 (0.11) 4.60 (6.99) 21.35 
VTYXVentyx Biosciences 0.10 7 per month 3.32  0.03  6.96 (5.86) 29.27 
IMCRImmunocore Holdings 1.03 9 per month 0.00 (0.10) 2.97 (3.87) 10.38 
PCVXVaxcyte(3.63)9 per month 2.24  0.03  3.32 (4.09) 42.81 
DICEDice Molecules Holdings 0.02 7 per month 1.14  0.11  5.66 (2.91) 37.64 
NUVLNuvalent(3.10)11 per month 2.76  0.03  3.84 (4.61) 36.85 
CGEMCullinan Oncology LLC(0.23)9 per month 0.00 (0.19) 5.88 (7.24) 17.85 
KNSAKiniksa Pharmaceuticals(0.28)10 per month 0.00 (0.15) 3.88 (3.69) 20.00 
VRDNViridian Therapeutics 0.43 11 per month 3.49  0.09  6.84 (5.29) 44.89 

Prothena Plc Additional Predictive Modules

Most predictive techniques to examine Prothena price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Prothena using various technical indicators. When you analyze Prothena charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Prothena Plc Predictive Indicators

The successful prediction of Prothena Plc stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Prothena plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Prothena Plc based on analysis of Prothena Plc hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Prothena Plc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Prothena Plc's related companies.
 2021 2023 2024 (projected)
Graham Number18.9525.6117.34
Receivables Turnover869.4417.7116.83

Story Coverage note for Prothena Plc

The number of cover stories for Prothena Plc depends on current market conditions and Prothena Plc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Prothena Plc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Prothena Plc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Prothena Plc Short Properties

Prothena Plc's future price predictability will typically decrease when Prothena Plc's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Prothena plc often depends not only on the future outlook of the potential Prothena Plc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prothena Plc's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding53.2 M
Cash And Short Term Investments618.8 M

Complementary Tools for Prothena Stock analysis

When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like